DIRECT BIOLOGICS LLC

In News

Exosomes: Company Spotlights from “A” to “Z” - BioInformant

BioInformant - Sep 17, 2026

Exosome Research Market Poised for Strong Growth as Diagnostic and Therapeutic Innovations Unlock New Opportunities, 2026–2035 - Procurement Magazine

Procurement Magazine - Sep 19, 2026

Acute Respiratory Distress Syndrome Market to Grow Steadily - GlobeNewswire

GlobeNewswire - Jun 03, 2026

AlloDirect Launches First Direct-to-Tissue-Bank Biologics Marketplace for Orthopedic Surgeons, ASCs, and Practices - Orthopedics This Week

Orthopedics This Week - Apr 24, 2026

Direct Biologics Gets New Look in Noncompete, Trade Secrets Case - Bloomberg Law News

Bloomberg Law News - Apr 04, 2023

Direct Biologics Announces FDA Approval for Proceeding With Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome - Newswire.com

Newswire.com - Jul 20, 2021

Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public - The Business Journals

The Business Journals - Sep 29, 2022

Direct Biologics LLC announced that it expects to receive $100 million in funding from IB Investments 1 LLC, and other investors - marketscreener.com

marketscreener.com - Sep 26, 2022

Direct Biologics - The Pharma Letter

The Pharma Letter - Jun 30, 2024

Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight - GlobeNewswire

GlobeNewswire - Sep 07, 2026

Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline - PR Newswire

PR Newswire - Dec 12, 2025

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment